Dapagliflozin versus sacubitril–valsartan for heart failure with mildly reduced or preserved ejection fraction

Ronen Arbel, Abed N. Azab, Mansi Oberoi, Enis Aboalhasan, Artyom Star, Khaled Elhaj, Fouad Khalil, Hilmi Alnsasra

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Dapagliflozin versus sacubitril–valsartan for heart failure with mildly reduced or preserved ejection fraction'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science